Medvolt.ai

Catalyst-Driven Access to Novel Molecular Scaffolds for Drug Discovery

A new enzymatic-photocatalytic method developed by UCSB and collaborators enables diversity-oriented synthesis of complex molecules, unlocking novel…

2 hrs ago • 

Medvolt.ai

August 2025

Regioselectivity Meets AI: Transforming Drug Discovery with Precision Chemistry

Regioselectivity refers to the preference of a chemical reaction to occur at one site on a molecule over another.

Aug 11 • 

Medvolt.ai

1

Ultimate Checklist: Preventing Common Pitfalls in Molecular Dynamics Simulations

Molecular Dynamics (MD) simulations have transformed the way we understand molecular systems, offering an unprecedented window into the dynamic behavior…

Aug 6 • 

Medvolt.ai

July 2025

Molecular Docking in Drug Discovery: Strengths, Shortcomings, and the Way Forward

Molecular docking has become a go-to method in many drug-discovery projects, often being the first choice for hit finding and even an initial step in…

Jul 28 • 

Medvolt.ai

Bridging Language and Chemistry: How Large Language Models Are Unlocking Structured Knowledge for Drug Discovery

Explore how large language models like Galactica and LLaMA-2 are revolutionizing drug discovery.

Jul 21 • 

Medvolt.ai

From Data to Drugs: How AI is Transforming the Future of Drug Discovery

AI is no longer a futuristic idea. It’s the new engine of biomedical innovation.

Jul 17 • 

Medvolt.ai

BBO-10203: A First-in-Class Cancer Therapeutic Engineered with AI, Supercomputing, and Structure-Based Precision

Introduction: From Undruggable to Clinically Viable

Jul 11 • 

Medvolt.ai

Chai-2 Redefines Antibody Discovery: AI-Driven De Novo Design with Industry-Leading Hit Rates

Chai-2 is the first AI model capable of generating fully functional antibodies in a zero-shot setting

Jul 1 • 

Medvolt.ai

June 2025

AlphaGenome: Google DeepMind’s Breakthrough Model for Predicting DNA Variant Effects with Unprecedented Precision

Google DeepMind has unveiled AlphaGenome, a new deep learning framework designed to predict the regulatory consequences of DNA sequence variations

Jun 26 • 

Medvolt.ai

Boltz-2: The New Benchmark for AI-Driven Binding Affinity Prediction in Drug Discovery

Boltz-2 is a pivotal step forward for the AI-powered drug discovery ecosystem.

Jun 20 • 

Medvolt.ai

May 2025

Meta’s OMol25 and UMA Models: Redefining the Future of Molecular Simulation

A major leap forward for the field of molecular machine learning: Meta FAIR and collaborators have released the Open Molecules 2025 (OMol25) dataset

May 24 • 

Medvolt.ai

Free Energy Methods and the Digital Transformation of Drug Discovery: Precision at Scale

The digital transformation of drug discovery isn’t just about AI—it’s about combining rigorous physics with scalable engineering.

May 15 • 

Medvolt.ai